Liabilities, Current in USD of Barinthus Biotherapeutics plc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Barinthus Biotherapeutics plc. quarterly Liabilities, Current history and change rate from Q4 2020 to Q3 2025.
Barinthus Biotherapeutics plc. Liabilities, Current for the quarter ending 30 Sep 2025 was $10.8M, a 28.4% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Barinthus Biotherapeutics plc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$10.8M	-$4.27M	-28.4%	30 Sep 2025	10-Q	07 Nov 2025
Q2 2025	$12.7M	-$2.86M	-18.4%	30 Jun 2025	10-Q	07 Aug 2025
Q1 2025	$12M	-$859K	-6.69%	31 Mar 2025	10-Q	07 May 2025
Q4 2024	$15.7M	+$3.06M	+24.3%	31 Dec 2024	10-Q	07 Nov 2025
Q3 2024	$15.1M	-$3.5M	-18.8%	30 Sep 2024	10-Q	06 Nov 2024
Q2 2024	$15.6M	+$3.48M	+28.7%	30 Jun 2024	10-Q	08 Aug 2024
Q1 2024	$12.8M	+$847K	+7.07%	31 Mar 2024	10-Q	13 May 2024
Q4 2023	$12.6M	+$356K	+2.91%	31 Dec 2023	10-K	20 Mar 2025
Q3 2023	$18.6M	+$4.54M	+32.3%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$12.1M	-$55K	-0.45%	30 Jun 2023	10-Q	10 Aug 2023
Q1 2023	$12M	-$4.5M	-27.3%	31 Mar 2023	10-Q	12 May 2023
Q4 2022	$12.2M	+$1.08M	+9.72%	31 Dec 2022	10-K	20 Mar 2024
Q3 2022	$14M	+$7.66M	+120%	30 Sep 2022	10-Q	10 Nov 2022
Q2 2022	$12.2M	+$3.62M	+42.4%	30 Jun 2022	10-Q	09 Aug 2022
Q1 2022	$16.5M	+$7.83M	+90.6%	31 Mar 2022	10-Q	11 May 2022
Q4 2021	$11.2M	+$3.52M	+46%	31 Dec 2021	10-K	24 Mar 2023
Q3 2021	$6.37M			30 Sep 2021	10-Q	12 Nov 2021
Q2 2021	$8.54M			30 Jun 2021	10-Q	12 Aug 2021
Q1 2021	$8.65M			31 Mar 2021	10-Q	14 Jun 2021
Q4 2020	$7.64M			31 Dec 2020	10-K	25 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.